Rise Biopharmaceuticals, Inc.
1 clinical trials · Sponsor
◉ Watch Rise Biopharmaceuticals, Inc.
| Record | Firm | Date |
|---|---|---|
| RP72 Monotherapy and in Combination With Gemcitabine in Patients With Pancreatic Cancer (NCT04338763) | Rise Biopharmaceuticals, Inc. | 2021-04-19 |
Track Rise Biopharmaceuticals, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.